Investors welcomed the news, with Tilray shares leaping nearly 10 percent on New York’s Nasdaq index as of 1530 GMT.
Canada pot grower Tilray enters pharma deal with Novartis’ Sandoz
More from Industry NewsMore posts in Industry News »
- Four COVID vaccines for children currently in trial phase: Govt tells Rajya Sabha
- Biocon ties up with Tabuk Pharmaceuticals to commercialise speciality medicines in Middle East
- Not enough orders, may cut Covishield output by 50%: SII
- Experts stress on Booster dose to avert third wave due to Omicron cases
- ZyCov-D, 4th vaccine in West Bengal, may be rolled out in mid-December